Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Anesthesiology. 2011 May;114(5):1190–1199. doi: 10.1097/ALN.0b013e318212515b

Table 3.

Overall effect of pharmacologic or genetic disruptions of the transient receptor potential vanilloid 1 on mortality, cytokine gene expression and serum nitrate/nitrite levels after cecal ligation and puncture or lipopolysaccharide challenge*

Cecal Ligation and Puncture

Perturbation Mortality Blood Culture Cytokine gene expression in splenocytes Serum levels
(168 h) Colony forming units/ml TNFα Time (h) CCL3 Time (h) IL-10 Time (h) Nitrate/Nitrite Time (h)

Pharmacologic 6 24 6 24 6 24 6 24 6 24
WT+RTX
Genetic
Trpv1-KO
Trpv1-KO+RTX
Lipopolysaccharide Challenge

Perturbation Mortality Cytokine gene expression in splenocytes Serum levels
(168 h) TNFα Time (h) CCL3 Time (h) IL-10 Time (h) Nitrate/Nitrite Time (h)

Pharmacologic 3 6 24 3 6 24 3 6 24 3 6 24
Capsazepine
Resiniferatoxin
Genetic
Trpv1-KO
*

Arrows pointing up or down indicate statistically significant effects (in the direction of the arrow) of given disruptions compared to respective controls and arrows pointing to the right indicate no significant effect. Cells were left empty when measurements were not obtained. CCL3 indicates macrophage inflammatory protein-1 α, IL-10 interleukin 10, RTX resiniferatoxin, TNFα tumor necrosis factor, Trpv1-KO animals lacking the transient receptor potential vanilloid 1gene, and WT wild-type.